MeiraGTx
MGTX
#6619
Rank
โ‚น62.58 B
Marketcap
โ‚น777.60
Share price
0.58%
Change (1 day)
49.58%
Change (1 year)

Revenue for MeiraGTx (MGTX)

Revenue in 2025 (TTM): โ‚น3.23 Billion

According to MeiraGTx's latest financial reports the company's current revenue (TTM ) is โ‚น3.40 Billion. In 2024 the company made a revenue of โ‚น2.85 Billion an increase over the revenue in the year 2023 that were of โ‚น1.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MeiraGTx from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น3.23 B13.16%
2024 โ‚น2.85 B144.66%
2023 โ‚น1.16 B-11.42%
2022 โ‚น1.31 B-53.05%
2021 โ‚น2.80 B146.54%
2020 โ‚น1.13 B20.09%
2019 โ‚น0.94 B
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
โ‚น57.73 B 1,593.88% Jersey
Novavax
NVAX
โ‚น92.08 B 2,601.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
โ‚น12.94 M-99.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚น1.96 B-42.40%๐Ÿ‡ฌ๐Ÿ‡ง UK